Informazioni cliniche
I vaccini aiutano a prevenire le infezioni, la trasmissione e quindi la diffusione di malattie o agenti patogeni come il tetano, la difterite, la Bordetella pertussis, il virus dell'encefalite da zecca (TBE), il virus del morbillo, il virus della parotite, il virus della rosolia o il virus della varicella zoster (VZV).
Diagnostica
I vaccini aiutano a prevenire le infezioni, la trasmissione e quindi la diffusione di malattie o agenti patogeni come il tetano, la difterite, la Bordetella pertussis, il virus dell'encefalite da zecca (TBE), il virus del morbillo, il virus della parotite, il virus della rosolia o il virus della varicella zoster (VZV).
Methods
| Technology | Parameter | Substrate | Species | Calibration | Ig Class | Format | Order No. |
|---|---|---|---|---|---|---|---|
| ELISA |
Anti-TBE Virus CSF ELISA 2.0 (IgG) tick-borne encephalitis virus |
antigen-coated microplate wells |
TBE viral proteins | 5/25/50/100/175/230 U/ml | IgG |
96 x 01 |
EI 2661-9601-2L G |
| ELISA |
Anti-TBE Virus CSF ELISA 2.0 (IgM) tick-borne encephalitis virus |
antigen-coated microplate wells |
TBE viral proteins | IgM |
96 x 01 |
EI 2661-9601-2L M | |
| ELISA |
CSQ pair of controls anti-VZV (IgG) |
IgG |
02 x 20 |
CK 2650-0220-L G | |||
| ELISA |
CSQ pair of controls anti-Rubella virus (IgG) |
IgG |
02 x 20 |
CK 2590-0220-L G | |||
| ELISA |
CSQ pair of controls anti-Measles virus (IgG) |
IgG |
02 x 20 |
CK 2610-0220-L G | |||
| ELISA |
CSQ pair of controls anti-Mumps virus (IgG) |
IgG |
02 x 20 |
CK 2630-0220-L G | |||
| ELISA |
CSF: Anti-Rubella Virus ELISA (IgG) Sample type: CSF/serum pair |
antigen-coated microplate wells |
native antigens, strain "HPV-77" |
5/25/50/100/175/230 U | IgG |
96 x 01 |
EI 2590-9601-L G |
| ELISA |
CSF: Anti-Measles Virus ELISA (IgG) Sample type: CSF/serum pair |
antigen-coated microplate wells |
native antigens from Measles virus |
5/25/50/100/175/230 U | IgG |
96 x 01 |
EI 2610-9601-L G |
| ELISA |
CSF: Anti-Mumps Virus ELISA (IgG) Sample type: CSF/serum pair |
antigen-coated microplate wells |
native antigens, strain "Enders" (ATCC VR-106) |
5/25/50/100 U | IgG |
96 x 01 |
EI 2630-9601-L G |
| IIFT | TBE virus (TBEV) |
infected and non- infected cells (2 BIOCHIPs per field) |
EU 14 | IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 |
FI 2661-1005 G FI 2661-1005 M FI 2661-1010 G FI 2661-1010 M |
|
| IIFT |
Flavivirus Mosaic 1 TBE virus (TBEV) West Nile virus (WNV) Japanese encephalitis virus (JEV) Yellow fever virus (YFV) |
4 BIOCHIPs per field: infected cells infected cells infected cells infected cells |
EU 14 EU 14 EU 14 EU 14 |
IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 |
FI 2661-1005-1 G FI 2661-1005-1 M FI 2661-1010-1 G FI 2661-1010-1 M |
|
| IIFT |
Flavivirus Profile 2 upper row: TBE virus (TBEV) West Nile virus (WNV) Japanese encephalitis virus (JEV) Yellow fever virus (YFV) bottom row: Dengue virus types 1 - 4 (DENV) |
infected cells infected cells infected cells infected cells infected cells |
EU 14 EU 14 EU 14 EU 14 EU 14 |
IgG IgM IgG IgM |
10 x 05 10 x 05 20 x 05 20 x 05 |
FI 2661-1005-2 G FI 2661-1005-2 M FI 2661-2005-2 G FI 2661-2005-2 M |
|
| ELISA |
Anti-TBE Virus ELISA 2.0 (IgG) tick-borne encephalitis virus |
antigen-coated microplate wells |
TBE viral proteins | IgG |
96 x 01 |
EI 2661-9601-2 G | |
| ELISA |
Anti-TBE Virus ELISA 2.0 (IgM) tick-borne encephalitis virus |
antigen-coated microplate wells |
semi-quantitative | IgM |
96 x 01 |
EI 2661-9601-2 M | |
| IIFT |
Varicella zoster virus (VZV) |
infected cells | EU 168 | IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 |
FI 2650-1005 G FI 2650-1005 M FI 2650-1010 G FI 2650-1010 M |
|
| ELISA |
Anti-VZV ELISA (IgA) Varicella zoster virus |
antigen-coated microplate wells |
native antigens from VZV |
semi-quantitative | IgA |
96 x 01 |
EI 2650-9601 A |
| ELISA |
Anti-VZV ELISA (IgG) Varicella zoster virus |
antigen-coated microplate wells |
native antigens from VZV |
10/100/500/5000 IU/l | IgG |
96 x 01 |
EI 2650-9601 G |
| ELISA |
Anti-VZV ELISA (IgM) Varicella zoster virus |
antigen-coated microplate wells |
native antigens from VZV |
semi-quantitative | IgM |
96 x 01 |
EI 2650-9601 M |
| ELISA |
Avidity: Anti-VZV ELISA (IgG) Varicella zoster virus avidity determination |
antigen-coated microplate wells |
native antigens from VZV |
10/100/500/5000 IU/l | IgG |
96 x 01 |
EI 2650-9601-1 G |
| ELISA |
Anti-VZV ELISA 2.0 (IgG) Varicella zoster virus |
antigen-coated microplate wells |
native antigens from VZV | IgG |
96 x 01 |
EI 2650-9601-2 G | |
| ELISA |
Anti-VZV Glycoprotein ELISA (IgM) Varicella zoster virus |
antigen-coated microplate wells |
native glycoproteins from VZV |
semi-quantitative | IgM |
96 x 01 |
EI 2650-9601-2 M |
| ChLIA | IDS VZV IgG | antigenic coated magnetic particles | VZV virus antigen |
quantitative |
50 x 01 |
IS-ID59031 | |
| ChLIA | IDS MMV IgG Control Set | 3 x 1.5 ml Control 1/2 | human serum |
2 concentrations |
IS-ID59301 | ||
| ChLIA | IDS VZV IgM | antigenic coated magnetic particles | VZV virus antigen |
quantitative |
50 x 01 |
IS-ID60031 | |
| ChLIA | IDS MMV IgM Control Set | 3 x 1.5 ml Control 1/2 | human serum |
2 concentrations |
IS-ID60301 | ||
| EUROArray | EUROArray HPV |
MN 2540-0505 MN 2540-0803 MN 2540-1005 MN 2540-2005 |
|||||
| ELISA |
Avidity: Anti-Rubella Virus ELISA (IgG) avidity determination |
antigen-coated microplate wells |
native antigens, strain "HPV-77" |
1/10/50/200 IU/ml | IgG |
96 x 01 |
EI 2590-9601-1 G |
| ELISA | Anti-Rubella Virus Glycoprotein ELISA (IgM) |
antigen-coated microplate wells |
native glycoproteins, strain "HPV-77" |
semi-quantitative | IgM |
96 x 01 |
EI 2590-9601-2 M |
| ELISA | Anti-Rubella Virus ELISA 2.0 (IgG) |
antigen-coated microplate wells |
Recombinant Rubella virus antigens |
IgG |
96 x 01 |
EI 2590-9601-3 G | |
| ChLIA | IDS Rubella IgG | antigenic coated magnetic particles | Rubella antigen |
quantitative |
100 x 01 |
IS-ID52011 | |
| ChLIA | IDS Rubella IgM | Anti-IgM-coated magnetic particles | Conjugate: Rubella antigen |
quantitative |
100 x 01 |
IS-ID52021 | |
| ChLIA | IDS Rubella Control Set | 3 x 1.5 ml Control 1/2 | human serum |
2 concentrations |
IS-ID52301 | ||
| ChLIA | IDS Rubella IgG Avidity | antigenic coated magnetic particles | Rubella antigen |
quantitative |
50 x 01 |
IS-ID53011 | |
| ChLIA | IDS Rubella Avidity Control Set | 3 x 1.0 ml Control 1/2 | human serum |
2 concentrations |
IS-ID53301 | ||
| ELISA | Anti-Bordetella pertussis toxin ELISA (IgA) |
antigen-coated microplate wells |
natives Bordetella pertussis toxin |
2/10/25/50 IU/ml | IgA |
96 x 01 |
EI 2050-9601 A |
| ELISA | Anti-Bordetella pertussis toxin ELISA (IgG) |
antigen-coated microplate wells |
natives Bordetella pertussis toxin |
5/25/100/200 IU/ml | IgG |
96 x 01 |
EI 2050-9601 G |
| ELISA | Anti-Bordetella pertussis ELISA (IgM) |
antigen-coated microplate wells |
inactivated Bordetella pertussis lysate |
semi-quantitative | IgM |
96 x 01 |
EI 2050-9601 M |
| ELISA | Anti-Bordetella FHA ELISA (IgA) |
antigen-coated microplate wells |
native Bordetella pertussis filamentous haemagglutinin |
2/10/25/50 IU/ml | IgA |
96 x 01 |
EI 2050-9601-3 A |
| ELISA | Anti-Bordetella FHA ELISA (IgG) |
antigen-coated microplate wells |
native Bordetella pertussis filamentous haemagglutinin |
5/25/100/200 IU/ml | IgG |
96 x 01 |
EI 2050-9601-3 G |
| ELISA | Anti-Influenza A Virus ELISA (IgA) |
antigen-coated microplate wells |
strains "Texas" (H3N2), "California" (H1N1) and "Singapore" (H1N1) |
semi-quantitative | IgA |
96 x 01 |
EI 2691-9601 A |
| ELISA | Anti-Influenza A Virus ELISA (IgG) |
antigen-coated microplate wells |
strains "Texas" (H3N2), "California" (H1N1) and "Singapore" (H1N1) |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2691-9601 G |
| ELISA | Anti-Influenza B Virus ELISA (IgA) |
antigen-coated microplate wells |
strain"Hong Kong 5/72" | semi-quantitative | IgA |
96 x 01 |
EI 2692-9601 A |
| ELISA | Anti-Influenza B Virus ELISA (IgG) |
antigen-coated microplate wells |
strain"Hong Kong 5/72" | 2/20/200 RU/ml | IgG |
96 x 01 |
EI 2692-9601 G |
| EUROLINE |
positive control serum: IgA, human, 50x concentrated for Bordetella pertussis |
IgA |
05 x 07 |
CL 2050-0507 A | |||
| EUROLINE |
positive control serum: IgG, human, 50x concentrated for Bordetella pertussis |
IgG |
05 x 07 |
CL 2050-0507 G | |||
| EUROLINE |
EUROLINE Bordetella pertussis (IgA) (FHA, PT, ACT separately) |
EUROLINE | IgA IgA |
16 x 01 240 x 01 |
DN 2050-1601 A DN 2050-24001 A |
||
| EUROLINE |
EUROLINE Bordetella pertussis (IgG) (FHA, PT, ACT separately) |
EUROLINE | IgG IgG |
16 x 01 240 x 01 |
DN 2050-1601 G DN 2050-24001 G |
||
| ELISA | Anti-Diphtheria Toxoid ELISA (IgG) |
antigen-coated microplate wells |
inactivated diphtheria toxin |
0.01/0.1/1/2 IU/ml | IgG |
96 x 01 |
EI 2040-9601 G |
| ELISA | Anti-Tetanus Toxoid ELISA (IgG) |
antigen-coated microplate wells |
inactivated tetanus toxin |
0,01/0,1/1/2/5 IU/ml | IgG |
96 x 01 |
EI 2060-9601 G |
| ELISA | Anti-Measles Virus ELISA (IgG) |
antigen-coated microplate wells |
native antigens from Measles virus |
50/250/1000/5000 IU/l | IgG |
96 x 01 |
EI 2610-9601 G |
| ELISA | Anti-Measles Virus ELISA (IgM) |
antigen-coated microplate wells |
native antigens from Measles virus |
semi-quantitative | IgM |
96 x 01 |
EI 2610-9601 M |
| ELISA |
Avidity: Anti-Measles Virus ELISA (IgG) avidity determination |
antigen-coated microplate wells |
native antigens from Measles virus |
50/250/1000/5000/5000 IU/l | IgG |
96 x 01 |
EI 2610-9601-1 G |
| ELISA | Anti-Measles Virus ELISA 2.0 (IgG) |
antigen-coated microplate wells |
native antigens from Measles virus |
quantitative | IgG |
96 x 01 |
EI 2610-9601-2 G |
| ELISA | Anti-Measles Virus NP ELISA (IgM) |
antigen-coated microplate wells |
recombinant nucleoprotein from Measles virus |
semi-quantitative | IgM |
96 x 01 |
EI 2610-9601-4 M |
| ELISA | Anti-Mumps Virus ELISA (IgG) |
antigen-coated microplate wells |
native antigens, strain "Enders" (ATCC VR-106) |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2630-9601 G |
| ELISA | Anti-Mumps Virus ELISA (IgM) |
antigen-coated microplate wells |
native antigens, strain "Enders" (ATCC VR-106) |
semi-quantitative | IgM |
96 x 01 |
EI 2630-9601 M |
| ELISA |
Anti-Mumps Virus AT ELISA (IgG) strains "Enders" and "Jeryl Lynn" |
antigen-coated microplate wells |
native antigens, strains "Enders" (ATCC VR-106) and "Jeryl Lynn" |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2630-9601-3 G |
| ELISA | Anti-Mumps Virus ELISA (G5) (IgM) |
antigen-coated microplate wells |
native antigens, genotype "G5" |
semi-quantitative | IgM |
96 x 01 |
EI 2630-9601-5 M |
| ChLIA | IDS Measles IgG | antigenic coated magnetic particles | Measles virus antigen |
quantitative |
50 x 01 |
IS-ID59011 | |
| ChLIA | IDS Mumps IgG | antigenic coated magnetic particles | Mumps virus antigen |
quantitative |
50 x 01 |
IS-ID59021 | |
| ChLIA | IDS Measles IgM | antigenic coated magnetic particles | Measles virus antigen |
quantitative |
50 x 01 |
IS-ID60011 | |
| ChLIA | IDS Mumps IgM | antigenic coated magnetic particles | Mumps virus antigen |
quantitative |
50 x 01 |
IS-ID60021 | |
| ChLIA | IDS Tetanus IgG | antigenic coated magnetic particles | Tetanus toxoid antigen |
quantitative |
100 x 01 |
IS-ID61011 | |
| ChLIA | IDS Tetanus IgG Control Set | 3 x 1.5 ml Control 1/2 | human serum |
2 concentrations |
IS-ID61301 | ||
|
* For research use only, not for in vitro diagnostic use in the sense of EU directive 98/79/EC. 1 Product manufactured by third party. Please contact your local Euroimmun representative for more information. | |||||||
Productfinder